Phase 1, Double-Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Trial of EirGenix' Pertuzumab and Perjeta® (Pertuzumab) Sourced From US and EU Administered to Healthy Male Volunteers
This trial is a single-center, single-dose, double-blind, parallel-group, randomized, 3-arm PK trial in healthy male volunteers comparing a biosimilar pertuzumab (EG1206A) to a single intravenous (i.v.) infusion to both European Union (EU) and United States of America (US) reference products.
/ CompletedNot ApplicableIIT Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING
The purpose of this study is to collect valid data from all forms of health care on the incidence, prevalence, the regional distribution, characteristics, management and outcomes of different ILDs under clinical practice conditions.
100 Clinical Results associated with Sacura GmbH
0 Patents (Medical) associated with Sacura GmbH
100 Deals associated with Sacura GmbH
100 Translational Medicine associated with Sacura GmbH